History
  • No items yet
midpage
625 F.3d 724
Fed. Cir.
2010
Read the full case

Background

  • '291 patent claims a genus of tetra-zine derivatives for cancer treatment; temozolomide is a key claimed compound and Temodar® was FDA-approved for two brain cancers.
  • Patent process began in 1982; initial office actions rejected claims for lack of utility; applicants pursued continuations and abandoned several applications.
  • Ownership transferred to Cancer Research in 1991; prosecution eventually led to issuance in 1993 after altered examiner positions.
  • Temozolomide received FDA approvals in 1999 and 2005; Barr filed ANDA in 2007; Cancer Research sued for patent infringement.
  • District court held the patent unenforceable for prosecution laches and inequitable conduct; on appeal the Federal Circuit reversed those findings.
  • Appellants seek reversal of the district court’s rulings based on the totality of prosecutorial delay and conduct evidence.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Prosecution laches based on delay and prejudice Barr argues delay caused prejudice via intervening rights Cancer Research argues unreasonable delay alone suffices without intervening rights Delay not proven unlawful; no intervening rights shown; reversal on laches
Inequitable conduct from withholding material data Barr shows data material and intent to deceive Cancer Research asserts no clear intent to deceive; data publication undermines inference District court erred; no clear intent established; inequitable conduct not proven

Key Cases Cited

  • Symbol Technologies, Inc. v. Lemelson Med., 422 F.3d 1378 (Fed. Cir. 2005) (prosecution laches requires totality of circumstances; intervening rights relevant)
  • Woodbridge v. United States, 263 U.S. 50 (S. Ct. 1923) (delay in patent issuance can constitute forfeiture)
  • Webster Electric Co. v. Splitdorf Electrical Co., 264 U.S. 463 (S. Ct. 1924) (unreasonable delay bar; intervening rights considered)
  • Crown Cork & Seal Co. v. Ferdinand Gutmann Co., 304 U.S. 159 (S. Ct. 1938) (absence of intervening rights; no excuse required for divisional delay)
  • General Talking Pictures Corp. v. Western Electric Co., 304 U.S. 175 (S. Ct. 1938) (intervening rights needed for laches in certain continuations)
  • In re Bogese, 303 F.3d 1362 (Fed. Cir. 2002) (PTO forfeiture based on delay and evidence of known developments)
Read the full case

Case Details

Case Name: Cancer Research Technology Limited and Schering v. Barr Laboratories
Court Name: Court of Appeals for the Federal Circuit
Date Published: Nov 9, 2010
Citations: 625 F.3d 724; 96 U.S.P.Q. 2d (BNA) 1937; 2010 WL 4455839; 2010 U.S. App. LEXIS 23214; 2010-1204
Docket Number: 2010-1204
Court Abbreviation: Fed. Cir.
Log In
    Cancer Research Technology Limited and Schering v. Barr Laboratories, 625 F.3d 724